Cytek Biosciences Cash Flow Statement
NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cytek Biosciences free cash flow
In fiscal 2025, Cytek Biosciences generated -$4.7 million of operating cash flow and spent $4.1 million on capital expenditures. That left free cash flow of -$8.8 million, a free-cash-flow margin of -4.4% of revenue. Free cash flow was down 140.1% from the prior year's $21.9 million.
Cytek Biosciences returned $15.1 million to shareholders through share repurchases.
Summary generated from market data by MetaCap's automated system. Methodology
Cytek Biosciences cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Net Income | -66.54M | -6.02M | -12.15M | 2.48M | 3.03M | 19.41M |
| Net Income growth (YoY) | — | — | -589.05% | -17.94% | -84.41% | — |
| Depreciation & Amortization | 7.58M | 7.21M | 6.05M | 2.49M | 1.24M | 603.00K |
| Stock-Based Compensation | 24.59M | 26.85M | 22.05M | 16.59M | 6.59M | 611.00K |
| Change in Working Capital | 59.19M | 58.92M | 34.28M | -12.96M | 10.19M | -7.88M |
| Operating Cash Flow | -4.69M | 25.38M | 5.28M | -12.23M | 4.63M | 15.16M |
| Capital Expenditures | -4.08M | -3.52M | -4.65M | -9.75M | -4.36M | -1.55M |
| Investing Cash Flow | 10.12M | -82.97M | -93.89M | -55.91M | -20.99M | -1.55M |
| Share Repurchases | -15.07M | -21.61M | -44.15M | 0 | 0 | — |
| Debt Issued | — | 0 | 0 | 2.98M | 0 | 0 |
| Debt Repaid | -4.75M | -557.00K | -565.00K | -50.00K | 0 | — |
| Financing Cash Flow | -13.43M | -15.82M | -41.81M | 5.51M | 213.56M | 122.61M |
| Net Change in Cash | -7.89M | -68.89M | -131.87M | -65.12M | 198.50M | 135.63M |
| Free Cash Flow | -8.77M | 21.85M | 633.00K | -21.98M | 266.00K | 13.61M |
This table shows 6 annual periods of Cytek Biosciences's cash flow statement, from FY 2025 back to FY 2020, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CTKB's reporting calendar. What is a cash flow statement?